Jacqueline Jonklaas
Overview
Explore the profile of Jacqueline Jonklaas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
3140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Carr A, Jenkins A, Jonklaas J, Gabriel K, Miller K, Graves K
JMIR Form Res
. 2025 Feb;
PMID: 39937181
Background: Patients diagnosed with differentiated thyroid cancer (DTC) who receive radioactive iodine (RAI) treatment experience acute, medium, and late treatment effects. The timing and severity of these effects varies by...
3.
Suresh A, Esposito G, Davidson B, Doroslovacki P, Jonklaas J
JCEM Case Rep
. 2024 Dec;
3(1):luae234.
PMID: 39678652
Patients with intermediate-risk thyroid cancers may undergo treatment with radioactive iodine-131 (I-131). They often undergo a pretreatment diagnostic iodine scan that typically shows areas of physiological uptake in the stomach,...
4.
Blazewicz A, Kielbus M, Skorzynska-Dziduszko K, Grabrucker A, Jonklaas J, Sosnowski P, et al.
Molecules
. 2024 Nov;
29(21).
PMID: 39519809
Background: Hypothyroidism (HT) affects millions worldwide and can lead to various lipid disorders. The metabolic complexity and the influence of toxic elements in autoimmune and non-autoimmune HT subtypes are not...
5.
6.
Jonklaas J, Carr A, Luta G, Yu C, Jensen R, Reasner E, et al.
Qual Life Res
. 2024 May;
33(7):2011-2023.
PMID: 38769210
Purpose: This study aimed to develop and psychometrically evaluate a patient-reported outcome measure (PROM), SAlivary, LAcrimal, NaSal (SALANS), to document patients' symptoms after radioactive iodine (RAI) treatment for differentiated thyroid...
7.
Bianco A, Dayan C, Jonklaas J
Front Endocrinol (Lausanne)
. 2024 Feb;
15:1369723.
PMID: 38379867
No abstract available.
8.
Jonklaas J
Expert Rev Endocrinol Metab
. 2023 Oct;
18(6):455-458.
PMID: 37811647
No abstract available.
9.
Jiang C, Wolf K, Kaakati R, Oh J, Yip A, Jonklaas J, et al.
Endocr Pract
. 2023 Aug;
29(10):787-793.
PMID: 37549880
Objective: There is no universal approach to the management of subclinical hypothyroidism (SCH). This study was designed to determine the impact of patient characteristics on management decisions in SCH amongst...
10.
Jonklaas J
Endocrine
. 2023 Jun;
84(2):293-300.
PMID: 37329413
Purpose: Hypothyroidism is a relatively common endocrine disorder and is well documented to be associated with lipid abnormalities. Methods: A narrative review was conducted of studies describing the alterations in...